LEMBO, David
 Distribuzione geografica
Continente #
NA - Nord America 7.144
EU - Europa 5.125
AS - Asia 2.852
AF - Africa 126
SA - Sud America 117
OC - Oceania 74
Continente sconosciuto - Info sul continente non disponibili 5
Totale 15.443
Nazione #
US - Stati Uniti d'America 6.999
IT - Italia 1.374
CN - Cina 1.328
DE - Germania 606
IE - Irlanda 559
SE - Svezia 541
SG - Singapore 441
FR - Francia 380
FI - Finlandia 306
UA - Ucraina 296
GB - Regno Unito 248
IN - India 231
KR - Corea 224
DK - Danimarca 169
PL - Polonia 154
VN - Vietnam 143
AT - Austria 117
ID - Indonesia 115
CA - Canada 113
CH - Svizzera 102
JP - Giappone 88
BR - Brasile 78
AU - Australia 68
SN - Senegal 45
BE - Belgio 43
TR - Turchia 42
IR - Iran 41
NL - Olanda 40
RU - Federazione Russa 36
TW - Taiwan 33
HK - Hong Kong 32
PK - Pakistan 29
ES - Italia 28
MX - Messico 27
RO - Romania 23
TH - Thailandia 23
BY - Bielorussia 22
CZ - Repubblica Ceca 22
IL - Israele 20
EG - Egitto 18
GR - Grecia 17
KE - Kenya 16
TN - Tunisia 16
MY - Malesia 15
ZA - Sudafrica 14
CL - Cile 13
PT - Portogallo 13
NO - Norvegia 12
UZ - Uzbekistan 8
EC - Ecuador 7
NG - Nigeria 7
PH - Filippine 7
AR - Argentina 6
CO - Colombia 6
NZ - Nuova Zelanda 6
PE - Perù 6
BD - Bangladesh 5
BH - Bahrain 4
HU - Ungheria 4
NP - Nepal 4
QA - Qatar 4
SA - Arabia Saudita 4
A1 - Anonimo 3
BG - Bulgaria 3
ET - Etiopia 3
LV - Lettonia 3
AE - Emirati Arabi Uniti 2
BZ - Belize 2
CR - Costa Rica 2
DZ - Algeria 2
EU - Europa 2
LK - Sri Lanka 2
MU - Mauritius 2
RS - Serbia 2
SI - Slovenia 2
AM - Armenia 1
CY - Cipro 1
GH - Ghana 1
IQ - Iraq 1
IS - Islanda 1
JO - Giordania 1
LB - Libano 1
LU - Lussemburgo 1
MT - Malta 1
NI - Nicaragua 1
OM - Oman 1
SL - Sierra Leone 1
SY - Repubblica araba siriana 1
UG - Uganda 1
UY - Uruguay 1
Totale 15.443
Città #
Chandler 811
Beijing 664
Dublin 558
Fairfield 545
Houston 490
Torino 418
Ashburn 325
Ann Arbor 306
Singapore 305
Woodbridge 286
Jacksonville 276
Wilmington 271
Redwood City 223
Seattle 211
Cambridge 205
Villeurbanne 199
Nyköping 196
Princeton 186
Medford 184
Turin 161
Pisa 138
Warsaw 121
Frankfurt am Main 112
Dearborn 111
Vienna 105
Jakarta 102
Dong Ket 90
Guangzhou 87
Milan 73
Boardman 62
Boston 53
Nanjing 49
Fremont 47
Helsinki 45
Santa Clara 44
San Diego 43
Norwalk 39
Alessandria 38
Shanghai 37
Toronto 36
Munich 35
Hangzhou 34
Geneva 33
Phoenix 27
Seoul 26
London 25
Verona 25
Brussels 23
Chengdu 23
Silver Spring 23
Taipei 23
New York 21
Xian 21
Jinan 20
Chennai 18
Tokyo 18
Upper Marlboro 18
Gravina In Puglia 17
Hefei 17
Lappeenranta 17
Mumbai 17
Ottawa 17
Tehran 17
Kunming 16
Lausanne 16
Bern 15
Duncan 15
Montréal 15
Mountain View 15
Paris 15
Siena 15
Wuhan 15
Bristol 14
Rome 14
Zhengzhou 14
Delhi 13
Falls Church 13
Hebei 13
San Mateo 13
Tianjin 13
Zurich 13
Changsha 12
Durban 12
Los Angeles 12
Renton 12
Changchun 11
Columbus 11
Guiyang 11
Harbin 11
Kolkata 11
Lachine 11
New Delhi 11
Prague 11
Bucharest 10
Detroit 10
Kuala Lumpur 10
Kumar 10
Nairobi 10
Napoli 10
Pune 10
Totale 9.230
Nome #
Broad-spectrum non-toxic antiviral nanoparticles with a virucidal inhibition mechanism 926
In vitro evaluation of the antiviral properties of Shilajit and investigation of its mechanisms of action 639
Anti-viral agents and composition thereof 405
Ficus religiosa L. bark extracts inhibit human rhinovirus and respiratory syncytial virus infection in vitro 302
Inactivation of high-risk human papillomaviruses by Holder pasteurization: implications for donor human milk banking 297
Anti-Cytomegalovirus Activity in Human Milk and Colostrum From Mothers of Preterm Infants 286
Nanomedicine formulations for the delivery of antiviral drugs: A promising solution for the treatment of viral infections 275
Inhibition of HSV-2 infection by pure compounds from Thymus capitatus extract in vitro 260
Micro- and nanobubbles: A versatile non-viral platform for gene delivery 228
Enhanced antiviral activity of acyclovir loaded into nanoparticles. 226
Preparation, characterization and in vitro antiviral activity evaluation of foscarnet-chitosan nanoparticles 224
Auto-associative heparin nanoassemblies: A biomimetic platform against the heparan sulfate-dependent viruses HSV-1, HSV-2, HPV-16 and RSV 203
Encapsulation of Acyclovir in new carboxylated cyclodextrin-based nanosponges improves the agent's antiviral efficacy 198
Thermosensitive and mucoadhesive pluronic-hydroxypropylmethylcellulose hydrogel containing the mini-CD4 M48U1 is a promising efficient barrier against HIV diffusion through macaque cervicovaginal mucus 195
Inhibition of herpes simplex-1 virus replication by 25-hydroxycholesterol and 27-hydroxycholesterol 180
The traditional use of Vachellia nilotica for sexually transmitted diseases is substantiated by the antiviral activity of its bark extract against sexually transmitted viruses 175
The agmatine-containing poly(amidoamine) polymer AGMA1 binds cell surface heparan sulfates and prevents the attachment of mucosal human papillomaviruses 174
New chitosan nanobubbles for ultrasound-mediated gene delivery: preparation and in vitro characterization 172
Additives for vaccine storage to improve thermal stability of adenoviruses from hours to months 160
25-Hydroxycholesterol and 27-hydroxycholesterol inhibit human rotavirus infection by sequestering viral particles into late endosomes 152
Agmatine-Containing Poly(amidoamine)s as a Novel Class of Antiviral Macromolecules: Structural Properties and In Vitro Evaluation of Infectivity Inhibition 151
A novel SWCNT platform bearing DOTA and b-cyclodextrin units. "One shot" multidecoration under microwave irradiation. 147
Anti-zika virus activity of polyoxometalates 147
Antiviral Activity of a Arisaema Tortuosum Leaf Extract and Some of its Constituents against Herpes Simplex Virus Type 2 146
Ethyl 1,8-Naphthyridone-3-carboxylates Downregulate Human Papillomavirus-16 (HPV-16) E6 and E7 Oncogenes Expression 145
Identification of Equine Lactadherin-derived Peptides That Inhibit Rotavirus Infection via Integrin Receptor Competition 144
Inhibition of human respiratory syncytial virus infectivity by a dendrimeric heparan sulfate-binding peptide. 140
In vitro screening for antiviral activity of Turkish plants revealing methanolic extract of Rindera lanata var. lanata active against human rotavirus 140
Effect of different non-conventional extraction methods on the antibacterial and antiviral activity of fucoidans extracted from Nizamuddinia zanardinii 137
High temperature-short time pasteurization has a lower impact on the antiviral properties of human milk than holder pasteurization 130
[Protein p53 inhibits the activity of the enhancer of the immediate-early genes of murine cytomegalovirus] 129
Highly Sulfated K5 Escherichia coli Polysaccharide Derivatives Inhibit Respiratory Syncytial Virus Infectivity in Cell Lines and Human Tracheal-Bronchial Histocultures 125
In vitro anti-herpes simplex virus-2 activity of Salvia desoleana Atzei & V. Picci essential oil 125
[Serum stimulates the transcriptional activity of the enhancer of the immediate-early genes of the murine cytomegalovirus through p21 ras] 122
The cholesterol metabolite 27-hydroxycholesterol inhibits SARS-CoV-2 and is markedly decreased in COVID-19 patients 118
Preparation and characterization of dextran nanobubbles for oxygen delivery 117
Acyclovir-loaded chitosan nanospheres from nano-emulsion templating for the topical treatment of herpesviruses infections 115
Inhibition of pathogenic non-enveloped viruses by 25-hydroxycholesterol and 27-hydroxycholesterol 114
Linear biocompatible glyco-polyamidoamines as dual action mode virus infection inhibitors with potential as broad-spectrum microbicides for sexually transmitted diseases 113
Trans-activation of the mouse cytomegalovirus immediate early gene enhancer by ras oncogenes 110
Filoviruses utilize glycosaminoglycans for their attachment to target cells 110
In vitro anti-Herpes simplex virus activity of crude extract of the roots of Nauclea latifolia Smith (Rubiaceae). 109
Modulation of HIV-LTR activity by ras oncogenes. 107
M48U1 and Tenofovir combination synergistically inhibits HIV infection in activated PBMCs and human cervicovaginal histocultures 105
Anti-zika virus and anti-usutu virus activity of human milk and its components 105
The thymidylate synthase inhibitor ZD1604 potently inhibits murine and human cytomegalovirus replication in quiescent fibroblasts 102
Virucidal metallic nanoparticles and use thereof 102
Antiviral oxysterols are present in human milk at diverse stages of lactation 98
Novel antipathogenic peptides = 复合保温防火板. 97
The Ifi 200 genes: an emerging family of IFN-inducible genes 97
[Early diagnosis of HCMV infections in patients undergoing transplantation of the kidney] 97
Constitutive expression of the interferon-inducible protein p202 in NIH 3T3 cells affects cell cycle progression. 96
Novel antipathogenic peptides 96
Oxysterols for use in the treatment and prevention of diseases caused by viruses 96
Human cytomegalovirus stimulates cellular dihydrofolate reductase activity in quiescent cells. 95
Sistemi non virali di rilascio di molecole di acido nucleico 95
Assay method for identifying inhibitors of the expression of the oncoproteins E6 and E7 of the human papilloma virus (Hpv), recombinant host cell and kit for use in the aforesaid method 92
Sviluppo ed utilizzo di un saggio cellulare ad alta resa per l’identificazione di inibitori dell’espressione delle oncoproteine E6 ed E7 di HPV-16 92
Early introduction of simulation in the medical curriculum: the MedInTo perspective 90
Agenti anti-virali e relative composizioni 90
Effect of high-risk human papillomavirus oncoproteins on p53R2 gene expression after DNA damage 90
Effect of interferon-alpha on immediate early gene expression of murine cytomegalovirus. 89
The AGMA1 poly(amidoamine) inhibits the infectivity of herpes simplex virus in cell lines, in human cervicovaginal histocultures, and in vaginally infected mice 89
A cell-based high-throughput assay for screening inhibitors of human papillomavirus-16 long control region activity 88
Expression of an altered ribonucleotide reductase activity associated with the replication of murine cytomegalovirus in quiescent fibroblasts 87
Molecular cloning of interferon-gamma inducible genes from a murine pre-B cell leukemia. 86
Preparation and in vitro evaluation of the antiviral activity of the acyclovir complex of a B-cyclodextrin/poly(amidoamine) copolymer 86
A novel polymeric nanoparticulate system for the delivery of antiviral drugs 86
Effect of industrial processing and storage procedures on oxysterols in milk and milk products. 85
Peptide-Derivatized SB105-A10 Dendrimer Inhibits the Infectivity of R5 and X4 HIV-1 Strains in Primary PBMCs and Cervicovaginal Histocultures. 85
Acyclovir-loaded sulfobutyl ether-β-cyclodextrin decorated chitosan nanodroplets for the local treatment of HSV-2 infections 85
The interferon-inducible 204 gene is transcriptionally activated by mouse cytomegalovirus and is required for its replication. M. DE ANDREA CO-FIRST AUTHOR 84
Novel broad spectrum virucidal molecules against enveloped viruses 84
Ficus religiosa L. bark extracts inhibit infection by herpes simplex virus type 2 in vitro 84
The human cytomegalovirus. 83
Extracellular vesicles in human preterm colostrum inhibit infection by human cytomegalovirus in vitro 83
Murine cytomegalovirus stimulates cellular thymidylate synthase gene expression in quiescent cells and requires the enzyme for replication. 82
The anticytomegaloviral activity of raltitrexed is abrogated in quiescent mouse fibroblasts that overexpress thymidylate synthase 78
Rhodanine derivatives as potent anti-HIV and anti-HSV microbicides 77
B19 virus infection in renal transplant recipients. 76
Sulfated K5 Escherichia coli polysaccharide derivatives: A novel class of candidate antiviral microbicides 76
Systèmes non-virales de délivrance de molécules d'acides nucleiques. / Nichtvirale Nukleinsäurenabgabesysteme. / Non-viral nucleic acid molecules delivery systems. FERRUTI PAOLO 75
Detection of SARS-CoV-2 in Milk From COVID-19 Positive Mothers and Follow-Up of Their Infants 74
The murine IFN-gamma receptor does not transduce the activation signal to a murine promoter in human cells 71
Sviluppo preclinico di un inibitore poliamidoaminico dell’infezione da Herpes Simplex Virus di tipo 1 e 2 70
Sviluppo di una nuova formulazione innovativa basata su nanocapsule per la veicolazione di amfotericina B. 69
In vitro anti-herpes activity of Salvia desoleana Atzei & V. Picci essential oil 69
Novel antipathogenic peptides 68
Biomedical and Related Applications of Second Generation Polyamidoamines 68
Colostrum from cows immunized with a veterinary vaccine against bovine rotavirus displays enhanced in vitro anti-human rotavirus activity 68
Sulfated derivatives of Escherichia coli K5 capsular polysaccharide are potent inhibitors of human cytomegalovirus. 67
Host genotype controls the ability of the ISGF3 complex to activate transcription of IFN-inducible genes. 67
cAMP response element of murine cytomegalovirus IE enhancer is transactivated by ras oncogenes 67
TGF-beta1 and IL-4 downregulate human papillomavirus-16 oncogene expression but have differential effects on the malignant phenotype of cervical carcinoma cells 67
The L1 protein of human papilloma virus 16 expressed by a fowlpox virus recombinant can assemble into virus-like particles in mammalian cell lines but elicits a non-neutralising humoral response 66
Procedimento di saggio per identificare inibitori dell’espressione delle oncoproteine E6 e E7 del papillomavirus umano (HPV), cellula ospite ricombinante e kit per l’uso nel suddetto procedimento 65
Production and use of the membranes associated with equine milk fat globules and use of equine lactadherin of apparent molecular mass 45 kDa in the prevention and treatment of rotavirus infections 65
Attività in vitro di derivati della dermaseptina S1 nei confronti di patogeni genitali. 64
Anti-viral agents and compositions thereof. / Agents antiviraux et compositions associées. 60
Tinkering with a viral ribonucleotide reductase 60
Totale 13.306
Categoria #
all - tutte 43.408
article - articoli 0
book - libri 0
conference - conferenze 3.293
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.701


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.408 0 0 0 269 181 376 248 241 395 302 206 190
2020/20212.233 141 167 167 135 195 148 212 151 289 169 140 319
2021/20222.028 154 96 129 184 121 91 165 123 97 112 345 411
2022/20232.826 257 183 77 209 306 726 189 180 338 75 178 108
2023/20241.665 173 212 80 110 104 171 150 108 29 129 158 241
2024/2025588 76 224 212 76 0 0 0 0 0 0 0 0
Totale 16.024